knowledge
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
Next article: JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
focus
leisure time
-
STAT letters to the editor on burnt
2025-09-05 06:30 -
Teach medical students about patients with intellectual disabilities
2025-09-05 06:11 -
In diabetes hearing, Sanders takes on a new foe: food makers
2025-09-05 05:50 -
Teach medical students about patients with intellectual disabilities
2025-09-05 05:07 -
Susan Tousi leaves Illumina to head cancer liquid biopsy startup
2025-09-05 05:03 -
Insitro, AI biotech unicorn, brings cash, new research to JPM 2024
2025-09-05 04:29